3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
17
Neoplasms
5
Neoplasm Metastasis
5
Colonic Neoplasms
4
Stomach Neoplasms
3
Ovarian Neoplasms
3
Lung Neoplasms
3
Gastrointestinal Neoplasms
3
Rectal Neoplasms
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myeloid, Acute
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Unresectable Metastatic Colorectal Cancer
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Sarcoma
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Melanoma
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Kidney Neoplasms
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Gastroesophageal Adenocarcinoma
1
Interventions
Folfox protocol
2
pembrolizumab
1
IFL protocol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Unresectable Metastatic Colorectal Cancer
×
IFL protocol
×
Clear all
NCT03692429
2020-11-20
alloSHRINK
Celyad Oncology SA
Phase 1
Recruiting
49 enrolled